Safety of inhaled (Tobi®) and intravenous tobramycin in young children with cystic fibrosis. [electronic resource]
Producer: 20150212Description: 428-34 p. digitalISSN:- 1873-5010
- Administration, Inhalation
- Administration, Intravenous
- Anti-Bacterial Agents -- administration & dosage
- Child, Preschool
- Cystic Fibrosis -- complications
- Female
- Follow-Up Studies
- Humans
- Infant
- Infant, Newborn
- Male
- Pseudomonas Infections -- complications
- Pseudomonas aeruginosa -- isolation & purification
- Retrospective Studies
- Tobramycin -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.